Nasal Azelastine Comparison Chart

This chart compares the indications and dosing for ASTEPRO® 0.15% and original azelastine 0.1%.

ASTEPRO 0.15% NDC# 0037-0243-30

ASTEPRO 0.15% Has No Generic Equivalent

  • Different formulation
    • ASTEPRO 0.15% has 50% greater concentration per spray than azelastine HCI 0.1% (205.5 mcg vs 137 mcg per spray)
  • Different dosing
    • ASTEPRO 0.15% is the first and only once-daily nasal antihistamine for seasonal allergic rhinitis
  • Different indication
    • ASTEPRO 0.15% is indicated to relieve both seasonal and perennial allergic rhinitis symptoms in patients 12 years of age and older
  • ASTEPRO 0.15% has no AB-rated generic equivalent
    • Please dispense ASTEPRO 0.15% as prescribed
 

Indication

ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Important Risk Information

  • Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
  • Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
  • In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
  • Pregnancy Category C: Based on animal data, may cause fetal harm
    Please see full Prescribing Information
    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088